EichorEICHOR
Study identifier: NCT04297683 Synced from ClinicalTrials.gov · August 05, 2026
● Active Not Recruiting

HEALEY ALS Platform Trial - Master Protocol

Condition: Amyotrophic Lateral Sclerosis  ·  Sponsor: Merit E. Cudkowicz, MD

PhasePhase 2/Phase 3
Planned participants1500
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The HEALEY ALS Platform Trial is a perpetual multi-center, multi-regimen clinical trial evaluating the safety and efficacy of investigational products for the treatment of ALS.

This description comes directly from the study's public registry record.

Talk to the study team

No contact information is available for this study as per the public registry record.

Always discuss trial participation with your own doctor first.

Locations (81)

Barrow Neurological InstitutePhoenix, Arizona, United States
Mayo Clinic ScottsdaleScottsdale, Arizona, United States
University of Arkansas for Medical SciencesLittle Rock, Arkansas, United States
UC San DiegoLa Jolla, California, United States
Loma Linda University HealthLoma Linda, California, United States
Kaiser Permanente Los Angeles Medical CenterLos Angeles, California, United States
University of Southern CaliforniaLos Angeles, California, United States
Cedars-Sinai Medical CenterLos Angeles, California, United States
University of California, IrvineOrange, California, United States
Forbes Norris MDA/ALS Research Center, California Pacific Medical CenterSan Francisco, California, United States
University of California, San FranciscoSan Francisco, California, United States
University of ColoradoAurora, Colorado, United States

+ 69 more locations — full list on the registry record.

Follow this study

Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.

We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →